关注
Montas Laporte
Montas Laporte
MD,PhD. UNICAMP
在 dac.unicamp.br 的电子邮件经过验证
标题
引用次数
引用次数
年份
Maternal health among Venezuelan women migrants at the border of Brazil
L Bahamondes, M Laporte, D Margatho, HSF de Amorim, C Brasil, ...
BMC Public Health 20, 1-8, 2020
502020
One‐year follow up on post‐placental IUD insertion: A randomized clinical trial
M Marangoni Jr, M Laporte, F Surita, MB Kraft, L Bahamondes, ...
Acta obstetricia et gynecologica Scandinavica 100 (4), 596-603, 2021
202021
Evaluation of clinical performance when intrauterine devices are inserted by different categories of healthcare professional
M Laporte, A Becerra, L Castro, N Veiga Jr, X Espejo‐Arce, ...
International Journal of Gynecology & Obstetrics 152 (2), 196-201, 2021
172021
Postplacental placement of intrauterine devices: A randomized clinical trial
M Laporte, M Marangoni Jr, F Surita, CT Juliato, M Miadaira, ...
Contraception 101 (3), 153-158, 2020
172020
Major differences in the characteristics of users of the copper intrauterine device or levonorgestrel intrauterine system at a clinic in Campinas, Brazil
M Laporte, S Metelus, M Ali, L Bahamondes
International Journal of Gynecology & Obstetrics 156 (2), 240-246, 2022
72022
Reasons for satisfaction with the use of the 52‐mg levonorgestrel intrauterine system
M Laporte, CM Charles, S Metelus, RB Souza, A Peloggia, ...
International Journal of Gynecology & Obstetrics 159 (2), 577-582, 2022
32022
Perspectives of health care providers regarding the levonorgestrel-releasing intrauterine system
M Laporte, A Peloggia, AC Marcelino, LS de Carvalho, L Bahamondes
The European Journal of Contraception & Reproductive Health Care 27 (3), 208-211, 2022
22022
Uptake, discontinuation, and continuation rate of long-acting contraceptive methods when offered at no cost in Campinas, Brazil
M Laporte, AC Marcelino, P da Cunha Pereira, X Espejo-Arce, CT Juliato, ...
Contraception 132, 110363, 2024
12024
Single‐visit long‐acting reversible contraception provision and pregnancy rates within 3 months
SI Manhiça, L Bahamondes, M Laporte, F Anjos, M Viscola, E Garcia, ...
International Journal of Gynecology & Obstetrics 161 (3), 1028-1032, 2023
12023
Reasons reported by women for choosing the levonorgestrel intrauterine system as a contraceptive method
M Laporte, CM Charles, S Metelus, A Peloggia, GO Paez, CT Juliato, ...
International Journal of Gynecology & Obstetrics 158 (3), 700-704, 2022
12022
Barriers to accessing post-pregnancy contraception in Brazil: The impact of COVID-19
CRT Juliato, M Laporte, F Surita, L Bahamondes
Best Practice & Research Clinical Obstetrics & Gynaecology, 102482, 2024
2024
Effectiveness and continuation rates of the etonogestrel‐subdermal contraceptive implant versus short‐acting contraceptive methods offered at no cost in Campinas, Brazil
M Laporte, AC Marcelino, P da Cunha Pereira, X Espejo‐Arce, CT Juliato, ...
International Journal of Gynecology & Obstetrics, 2024
2024
Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition
JBE Versailles, S Metelus, A Peloggia, M Laporte, L Bahamondes, ...
The European Journal of Contraception & Reproductive Health Care 28 (4), 207-209, 2023
2023
ASPECTOS CLÍNICOS DO USO E DA INSERÇÃO DO DISPOSITIVO INTRAUTERINO HORMONAL (52 mg) E DO DISPOSITIVO INTRAUTERINO COM COBRE (DIU-TCu380A)
M Laporte
系统目前无法执行此操作,请稍后再试。
文章 1–14